Myriad Genetics (MYGN) Intangibles (2016 - 2025)
Historic Intangibles for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to $163.1 million.
- Myriad Genetics' Intangibles fell 4780.8% to $163.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.1 million, marking a year-over-year decrease of 4780.8%. This contributed to the annual value of $262.4 million for FY2024, which is 2492.13% down from last year.
- As of Q3 2025, Myriad Genetics' Intangibles stood at $163.1 million, which was down 4780.8% from $170.1 million recorded in Q2 2025.
- Myriad Genetics' 5-year Intangibles high stood at $559.9 million for Q1 2021, and its period low was $163.1 million during Q3 2025.
- In the last 5 years, Myriad Genetics' Intangibles had a median value of $358.8 million in 2023 and averaged $347.0 million.
- In the last 5 years, Myriad Genetics' Intangibles tumbled by 382.96% in 2023 and then tumbled by 4780.8% in 2025.
- Myriad Genetics' Intangibles (Quarter) stood at $404.1 million in 2021, then decreased by 6.04% to $379.7 million in 2022, then fell by 7.95% to $349.5 million in 2023, then decreased by 24.92% to $262.4 million in 2024, then plummeted by 37.84% to $163.1 million in 2025.
- Its Intangibles stands at $163.1 million for Q3 2025, versus $170.1 million for Q2 2025 and $257.5 million for Q1 2025.